To direct the Comptroller General of the United States to conduct a study on how direct-to-consumer pharmaceutical advertising negatively impacts drug costs to consumers, and for other purposes.
TQL analysis
Not yet gradedThis bill has no published Quiet Ledger grade yet.
Legislative structure
Criterion breakdown8 criteria · max 90
No grade to break down.Actions (3)
| Date | Time | Action |
|---|---|---|
| 2021-06-30 | — | Referred to the House Committee on Energy and Commerce. |
| 2021-06-30 | — | Introduced in House |
| 2021-06-30 | — | Introduced in House |
The Quiet Ledger grades legislation on its content. A bill grade is analysis of the bill — not a grade of its sponsor or of any member who voted on it.